Cargando…

Beraprost and Overall Survival in Cats with Chronic Kidney Disease

SIMPLE SUMMARY: Chronic kidney disease (CKD) is a highly prevalent disorder in senior cats. CKD is commonly diagnosed together with other disorders; therefore, overall survival, based on all-cause death, including complications, is the most important outcome for treatment response in feline CKD. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Hiroyuki, Matsuura, Takumi, Sano, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384921/ https://www.ncbi.nlm.nih.gov/pubmed/37505864 http://dx.doi.org/10.3390/vetsci10070459

Ejemplares similares

A Double‐blind, Placebo‐controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease
por: Takenaka, M., et al.
Publicado: (2017)

Catalytic asymmetric formal synthesis of beraprost
por: Kobayashi, Yusuke, et al.
Publicado: (2015)

Beraprost sodium protects against chronic brain injury in aluminum-overload rats
por: Pan, Yongquan, et al.
Publicado: (2015)

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial
por: Koyama, Akio, et al.
Publicado: (2015)

Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease
por: Yoon, Hang Seob, et al.
Publicado: (2013)

Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats
por: Ahmad, Shafique, et al.
Publicado: (2018)

Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction
por: Wang, Li, et al.
Publicado: (2019)

The association of bacteriuria with survival and disease progression in cats with azotemic chronic kidney disease
por: Hindar, Camilla, et al.
Publicado: (2020)

Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy
por: Na, Ki Young, et al.
Publicado: (2013)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination
por: Zheng, Huo-Liang, et al.
Publicado: (2021)

Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis
por: Yan, Peng, et al.
Publicado: (2023)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats
por: Sato, Nahoko, et al.
Publicado: (2010)

Renal diets in cats with chronic kidney disease
por: Dean, Rachel, et al.
Publicado: (2015)

Iron Status of Cats with Chronic Kidney Disease
por: Gest, J., et al.
Publicado: (2015)

De Novo Synthesis of Dihydrobenzofurans and Indolines and Its Application to a Modular, Asymmetric Synthesis of Beraprost
por: Wang, Ze-Shu, et al.
Publicado: (2023)

Serum concentrations of gabapentin in cats with chronic kidney disease
por: Quimby, Jessica M, et al.
Publicado: (2022)

Risk Factors for Development of Chronic Kidney Disease in Cats
por: Finch, N.C., et al.
Publicado: (2016)

Chronic Kidney Disease in Cats and the Risk of Total Hypercalcemia
por: van den Broek, D.H.N., et al.
Publicado: (2017)

Assessment of peritubular capillary rarefaction in kidneys of cats with chronic kidney disease
por: Paschall, Rene E., et al.
Publicado: (2023)

Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus
por: Otsuki, Michio, et al.
Publicado: (2005)

Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study
por: Cai, De, et al.
Publicado: (2019)

Immunohistochemical Expression of TGF-β1 in Kidneys of Cats with Chronic Kidney Disease
por: Uehara, Yuki, et al.
Publicado: (2022)

Changes in Systolic Blood Pressure over Time in Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2015)

Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria
por: Choi, Yun Mi, et al.
Publicado: (2019)

Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis
por: Liang, Xinyu, et al.
Publicado: (2022)

Dysbiosis of the Urinary Bladder Microbiome in Cats with Chronic Kidney Disease
por: Kim, Younjung, et al.
Publicado: (2021)

Development and validation of a novel nomogram to predict overall survival of patients with moderate to severe chronic kidney disease
por: Li, Ning, et al.
Publicado: (2022)

Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease
por: Loane, Samantha C., et al.
Publicado: (2022)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Relationship between Plasma Fibroblast Growth Factor‐23 Concentration and Survival Time in Cats with Chronic Kidney Disease
por: Geddes, R.F., et al.
Publicado: (2015)

Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats
por: Ghys, L.F.E., et al.
Publicado: (2016)

Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease
por: De Santis, Francesca, et al.
Publicado: (2022)

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
por: Xu, Xinwei, et al.
Publicado: (2020)

Beraprost sodium attenuates the development of myocardial fibrosis after myocardial infarction by regulating GSK‐3β expression in rats
por: Li, Xing‐Xing, et al.
Publicado: (2023)

Serum and Fecal Amino Acid Profiles in Cats with Chronic Kidney Disease
por: Summers, Stacie C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_od5rqep8qvj9d1g9b3h78c8ncv